Navigation Links
AST on Capitol Hill to Promote Transplant Drug Extension Provision With Senate as Part of Health Care Reform
Date:10/8/2009

WASHINGTON, Oct. 8 /PRNewswire/ -- As Congress wraps up work on health care reform, members of the American Society of Transplantation's (AST) Public Policy Committee arrived on Capitol Hill today to discuss the importance of supporting a health care provision that would ensure kidney transplant recipients continue to receive Medicare coverage for immunosuppressive drugs. The Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009, in the health care reform bill, is currently on the floor of the U.S. Senate and has been included in the House health care reform bill. Extending immunosuppressive coverage under Medicare will improve the long term health of kidney recipients and is cost-effective to taxpayers.

While on Capitol Hill, AST Public Policy members will meet with congressional representatives of the Senate Appropriations Committee, House Energy and Commerce Committee, House Ways and Means Committee, House Science Committee, and House Education and Labor Subcommittee on Families and Community.

Medicare and Immunosuppressive Drug Coverage

The Medicare Program pays for kidney transplantation, an initial investment of more than $100,000. By providing Medicare coverage for a patient's immunosuppressant drugs, the Medicare transplant investment is protected and preserved. Most individuals with end stage renal disease (ESRD) are eligible for Medicare regardless of age or other disability. Under current law kidney transplant recipients, if not aged or disabled, lose their Medicare immunosuppressive drug coverage 36 months post-transplant. Without such drugs, a transplanted kidney may fail and Medicare is then faced with re-transplantation or a return to costly dialysis. By contrast, there is no Medicare time or cost limit for dialysis patients. Medicare spends approximately $70,000 per dialysis beneficiary every year.

About the AST Public Policy Committee

AST represents the majority of professionals engaged in the field of solid organ transplantation. The AST Public Policy Committee regularly delivers AST's message to Congress and the Administration. This strategy has been effective in ensuring that members of Congress and Capitol Hill staff are aware of the issues that impact transplantation.

About AST

The American Society of Transplantation is an international organization of transplant professionals dedicated to advancing the field of transplantation through the promotion of research, education, advocacy, and organ donation to improve patient care. The Society comprises over 3,100 transplant physicians, surgeons and allied health professionals.

For information about AST, visit www.a-s-t.org.

    CONTACT: BETH DROST
    (215) 884-6499
    beth@comsolutionsgroup.com

SOURCE American Society of Transplantation


'/>"/>
SOURCE American Society of Transplantation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) Supports Panel Discussion on Women and Lung Cancer on Capitol Hill
2. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
3. Vical Promotes Melanoma Awareness Month With Allovectin-7(R) Video Report
4. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
5. National Stem Cell Holding, Inc. Discovers Non-Embryonic Biomaterials that Promote Tissue Repair
6. U.S. FDA Authorizes Expansion to 40 Clinical Sites for HeartWare U.S. Bridge-to-Transplant Clinical Trial
7. WORLDS First Robotic Assisted Kidney Transplant Performed at Saint Barnabas Medical Center
8. IMPACT Study Showed Longer Valcyte(R) (valganciclovir hydrochloride tablets) Treatment Demonstrated Better Protection Against Cytomegalovirus (CMV) Disease One Year Post-Transplant
9. Three Independent Studies Include the ImmuKnow(R) Assay to Manage and Optimize Immunosuppression Therapy in Transplant Patients
10. Living Donor Kidney Transplants Using Alemtuzumab Pre-Conditioning and Tacrolimus Monotherapy: Long-Term Safety and Efficacy
11. Lions Eye Institute for Transplant & Research, Inc. Launches Multi-Million Dollar, State-of-the-Art Research Institute that Will Advance the Study of Blinding Eye Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... /PRNewswire/--  Cell Applications, Inc. and Cyfuse Biomedical ... now available in North America ... approach called the "Kenzan Method." Utilizing Cyfuse Biomedical,s ... robotic system that fabricates 3D tissue from cells, ... model that makes scaffold-free tissue available immediately to ...
(Date:2/8/2016)... Velano Vascular, a medical technology company transforming ... their practitioners, announced today that the company has raised ... the proceeds from this financing, an extension of a ... to support the development and commercialization of the company,s ... Philadelphia , and a number ...
(Date:2/8/2016)... 2016  Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS ... delivery systems, today announced that it will release its financial ... 2015 after market close on February 9, 2016.  At this ... discuss these financial results.    About Unilife Corporation ... About Unilife Corporation UNIS ...
Breaking Medicine Technology:
(Date:2/8/2016)... ... February 08, 2016 , ... Delta Dental of California and its affiliated companies ... Gary D. Radine, who recently retired as president and CEO of Delta Dental of ... CEO of the Year , helped lead the effort to raise funds for studies ...
(Date:2/8/2016)... ... 08, 2016 , ... Eating disorders and post-traumatic stress disorder ... and men with eating disorders report a history of trauma, research suggests that ... an eating disorder. , At the 2016 iaedp Symposium, the workshop, “What ...
(Date:2/8/2016)... ... 08, 2016 , ... GrassrootsHealth published data from its D*action ... diabetes in the GrassrootsHealth cohort with substantially higher vitamin D levels than a ... health,” states Carole Baggerly, Director of GrassrootsHealth, “the safety and benefits of ...
(Date:2/8/2016)... Vegas, Nevada (PRWEB) , ... February 08, 2016 ... ... at RowdMap, Inc., will be speaking on how healthcare companies can use newly ... costs, manage the health of a population and intervene and capture the value ...
(Date:2/8/2016)... ... 2016 , ... According to research by the National Association ... to be certified or obtain continuing education. To increase patient awareness of the ... Mouth?” campaign to inform dentists and patients about the possible lack of skills ...
Breaking Medicine News(10 mins):